WEDNESDAY, March 11, 2026 — The U.S. Food and Drug Administration (FDA) has approved a generic drug for a very rare brain disorder, but said it should not be considered a treatment for autism.
On Tuesday, the agency cleared leucovorin for…
Blog
Leave a Reply